SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission#South_Korea#Seongnam#Influenza_vaccine#SK_bioscience#adjuvant_technology
SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission
SK bioscience has submitted an IND application for a Phase 1/2 clinical trial of a new adjuvanted influenza vaccine, aiming to enhance protective efficacy for vulnerable populations.
third-news.com
July 17, 2025 at 11:08 AM
SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission#South_Korea#Seongnam#Influenza_vaccine#SK_bioscience#adjuvant_technology